Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Accepteret manuskript, 492 KB, PDF-dokument
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetes, Obesity and Metabolism |
Vol/bind | 25 |
Udgave nummer | 4 |
Sider (fra-til) | 1125-1129 |
Antal sider | 5 |
ISSN | 1462-8902 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
The ELIXA trial was funded by Sanofi.
ID: 359084834